Publicacions en què col·labora amb Piero Crespo (2)

2022

  1. Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma

    Biomolecules, Vol. 12, Núm. 11

2002

  1. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2

    Molecular and Cellular Biology, Vol. 22, Núm. 1, pp. 270-285